Opthea Ltd (OPT)
3.39
+0.07
(+2.11%)
USD |
NASDAQ |
May 03, 11:31
Opthea Enterprise Value: 118.00M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 118.00M |
| May 01, 2024 | 115.10M |
| April 30, 2024 | 119.65M |
| April 29, 2024 | 113.85M |
| April 26, 2024 | 124.62M |
| April 25, 2024 | 143.68M |
| April 24, 2024 | 127.11M |
| April 23, 2024 | 121.31M |
| April 22, 2024 | 122.97M |
| April 19, 2024 | 116.34M |
| April 18, 2024 | 124.62M |
| April 17, 2024 | 124.62M |
| April 16, 2024 | 136.22M |
| April 15, 2024 | 137.88M |
| April 12, 2024 | 157.76M |
| April 11, 2024 | 166.05M |
| April 10, 2024 | 166.88M |
| April 09, 2024 | 178.48M |
| April 08, 2024 | 153.62M |
| April 05, 2024 | 174.33M |
| April 04, 2024 | 166.05M |
| April 03, 2024 | 170.19M |
| April 02, 2024 | 170.19M |
| April 01, 2024 | 185.93M |
| March 28, 2024 | 183.45M |
| Date | Value |
|---|---|
| March 27, 2024 | 166.88M |
| March 26, 2024 | 150.31M |
| March 25, 2024 | 149.48M |
| March 22, 2024 | 156.11M |
| March 21, 2024 | 131.25M |
| March 20, 2024 | 129.60M |
| March 19, 2024 | 123.80M |
| March 18, 2024 | 123.80M |
| March 15, 2024 | 128.77M |
| March 14, 2024 | 132.91M |
| March 13, 2024 | 120.48M |
| March 12, 2024 | 118.82M |
| March 11, 2024 | 123.80M |
| March 08, 2024 | 118.82M |
| March 07, 2024 | 120.48M |
| March 06, 2024 | 108.88M |
| March 05, 2024 | 130.42M |
| March 04, 2024 | 125.45M |
| March 01, 2024 | 134.57M |
| February 29, 2024 | 145.34M |
| February 28, 2024 | 142.02M |
| February 27, 2024 | 135.39M |
| February 26, 2024 | 113.85M |
| February 23, 2024 | 127.11M |
| February 22, 2024 | 110.54M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.12M
Minimum
Sep 22 2023
686.76M
Maximum
Sep 09 2019
252.37M
Average
222.26M
Median
Dec 07 2022
Enterprise Value Benchmarks
| Immutep Ltd | -- |
| Kazia Therapeutics Ltd | 5.265M |
| Bionomics Ltd | 0.576M |
| Alterity Therapeutics Ltd | -- |
| Mesoblast Ltd | -- |
Enterprise Value Related Metrics
| Earnings Yield | -70.97% |
| Normalized Earnings Yield | -70.09 |